PRME
Prime Medicine
Stock NYSE Arca – Stock Market Prices, News & Analysis
Biotechnology company specializing in the development of gene therapies to treat rare genetic disorders.
$ 4.13
7.83 %
Prime Medicine
$
4.13
7.83 %
PRME
Biotechnology company specializing in the development of gene therapies to treat rare genetic disorders.
Price history of Prime Medicine
Price history of Prime Medicine
Performance & Momentum
6 Months
13.77 %
1 Year
62.60 %
3 Years
76.47 %
5 Years
73.79 %
Momentum
79
Similar stocks to Prime Medicine
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
